Stephen R Bowen

Dr. Stephen R Bowen

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2023 in British Journal of Radiology
Verified
Journal Article
Open access
LWLise Wei
Lise Wei
DNDipesh Niraula
Dipesh Niraula
EGEvan D H Gates
Evan D H Gates
JFJie Fu
Jie Fu
YLYi Luo
Yi Luo
SCSunan Cui
Sunan Cui
Multiomics data including imaging radiomics and various types of molecular biomarkers have been increasingly investigated for better diagnosis and therapy in the era of precision oncology. Artificial intelligence (AI) including machine learning (ML) and deep learning (DL) techniques combined with the exponential growth of multiomics data may have great potential to revolutionize cancer subtyping, risk stratification, prognostication, prediction and clinical decision-making. In this article, we first present different categories of multiomics data and their roles in diagnosis and therapy. Second, AI-based data fusion methods and modeling methods as well as different validation schemes are illustrated. Third, the applications and examples of multiomics research in oncology are demonstrated. Finally, the challenges regarding the heterogeneity data set, availability of omics data, and validation of the research are discussed. The transition of multiomics research to real clinics still requires consistent efforts in standardizing omics data collection and analysis, building computational infrastructure for data sharing and storing, developing advanced methods to improve data fusion and interpretability, and ultimately, conducting large-scale prospective clinical trials to fill the gap between study findings and clinical benefits.

5 August 2015 in Journal of Medical Imaging
Verified
Journal Article
Open access
PDF file
MNMatthew J. Nyflot
Matthew J. Nyflot
FYFei Yang
Fei Yang
DBDarrin Byrd
Darrin Byrd
SBStephen R Bowen
Stephen R Bowen
GSGeorge A. Sandison
George A. Sandison
PKPaul E Kinahan
Paul E Kinahan
Image heterogeneity metrics such as textural features are an active area of research for evaluating clinical outcomes with positron emission tomography (PET) imaging and other modalities. However, the effects of stochastic image acquisition noise on these metrics are poorly understood. We performed a simulation study by generating 50 statistically independent PET images of the NEMA IQ phantom with realistic noise and resolution properties. Heterogeneity metrics based on gray-level intensity histograms, co-occurrence matrices, neighborhood difference matrices, and zone size matrices were evaluated within regions of interest surrounding the lesions. The impact of stochastic variability was evaluated with percent difference from the mean of the 50 realizations, coefficient of variation and estimated sample size for clinical trials. Additionally, sensitivity studies were performed to simulate the effects of patient size and image reconstruction method on the quantitative performance of these metrics. Complex trends in variability were revealed as a function of textural feature, lesion size, patient size, and reconstruction parameters. In conclusion, the sensitivity of PET textural features to normal stochastic image variation and imaging parameters can be large and is feature-dependent. Standards are needed to ensure that prospective studies that incorporate textural features are properly designed to measure true effects that may impact clinical outcomes.

16 October 2017 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
SBStephen R Bowen
Stephen R Bowen
WYWilliam T.C. Yuh
William T.C. Yuh
DHDaniel S. Hippe
Daniel S. Hippe
WWWei Wu
Wei Wu
SPSavannah C. Partridge
Savannah C. Partridge
NMNina A. Mayr
Nina A. Mayr

28 April 2017 in Medical Physics
Verified
Journal Article
Closed access
PDF file
ELEunsin Lee
Eunsin Lee
JZJing Zeng
Jing Zeng
RMRobert S. Miyaoka
Robert S. Miyaoka
JSJatinder Saini
Jatinder Saini
PKPaul E Kinahan
Paul E Kinahan
SBStephen R Bowen
Stephen R Bowen

26 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
PFPARISA FOROUZANNEZHAD
PARISA FOROUZANNEZHAD
DMDominic Maes
Dominic Maes
DHDaniel S Hippe
Daniel S Hippe
PTPhawis Thammasorn
Phawis Thammasorn
RIReza Iranzad
Reza Iranzad
SBStephen R Bowen
Stephen R Bowen
Medical imaging provides quantitative and spatial information to evaluate treatment response in the management of patients with non-small cell lung cancer (NSCLC). High throughput extraction of radiomic features on these images can potentially phenotype tumors non-invasively and support risk stratification based on survival outcome prediction. The prognostic value of radiomics from different imaging modalities and time points prior to and during chemoradiation therapy of NSCLC, relative to conventional imaging biomarker or delta radiomics models, remains uncharacterized. We investigated the utility of multitask learning of multi-time point radiomic features, as opposed to single-task learning, for improving survival outcome prediction relative to conventional clinical imaging feature model benchmarks. Survival outcomes were prospectively collected for 45 patients with unresectable NSCLC enrolled on the FLARE-RT phase II trial of risk-adaptive chemoradiation and optional consolidation PD-L1 checkpoint blockade (NCT02773238). FDG-PET, CT, and perfusion SPECT imaging pretreatment and week 3 mid-treatment was performed and 110 IBSI-compliant pyradiomics shape-/intensity-/texture-based features from the metabolic tumor volume were extracted. Outcome modeling consisted of a fused Laplacian sparse group LASSO with component-wise gradient boosting survival regression in a multitask learning framework. Testing performance under stratified 10-fold cross-validation was evaluated for multitask learning radiomics of different imaging modalities and time points. Multitask learning models were benchmarked against conventional clinical imaging and delta radiomics models and evaluated with the concordance index (c-index) and index of prediction accuracy (IPA). FDG-PET radiomics had higher prognostic value for overall survival in test folds (c-index 0.71 [0.67, 0.75]) than CT radiomics (c-index 0.64 [0.60, 0.71]) or perfusion SPECT radiomics (c-index 0.60 [0.57, 0.63]). Multitask learning of pre-/mid-treatment FDG-PET radiomics (c-index 0.71 [0.67, 0.75]) outperformed benchmark clinical imaging (c-index 0.65 [0.59, 0.71]) and FDG-PET delta radiomics (c-index 0.52 [0.48, 0.58]) models. Similarly, the IPA for multitask learning FDG-PET radiomics (30%) was higher than clinical imaging (26%) and delta radiomics (15%) models. Radiomics models performed consistently under different voxel resampling conditions. Multitask learning radiomics for outcome modeling provides a clinical decision support platform that leverages longitudinal imaging information. This framework can reveal the relative importance of different imaging modalities and time points when designing risk-adaptive cancer treatment strategies.

1 May 2015 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
SBStephen R Bowen
Stephen R Bowen
JSJatinder Saini
Jatinder Saini
TCTobias R. Chapman
Tobias R. Chapman
RMRobert S. Miyaoka
Robert S. Miyaoka
PKPaul E Kinahan
Paul E Kinahan
SASmith Apisarnthanarax
Smith Apisarnthanarax